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Class 3 semaphorins are guidance proteins that play crucial
roles during development. Semaphorins 3A (sema 3A) and 3F
are expressed by podocytes in vivo throughout ontogeny and
their function is unknown. Here we examined the expression
of class 3 semaphorins (3A, 3B, 3C, 3D, 3E, and 3F) and their
receptors (neuropilins 1 and 2, plexins A1, A2, A3, B2, and D1)
in undifferentiated and differentiated mouse podocytes
using reverse transcriptase-polymerase chain reaction
(RT-PCR). All class 3 semaphorins, neuropilins 1 and 2 are
expressed by undifferentiated and differentiated podocytes
at similar levels. Differentiated podocytes expressed
2–4-fold higher plexin A1, A2, and A3 mRNA levels than
undifferentiated podocytes. To examine semaphorin
regulation, we exposed podocytes to recombinant sema 3A.
Sema 3A decreased semaphorin 3B, plexin A1, A3, and D1
X50% and reduced plexin A2 mRNA to undetectable levels.
To identify sema 3A function in podocytes, we examined
whether sema 3A regulates slit diaphragm proteins and
podocyte survival. Sema 3A induced a dose-response
podocin downregulation and decreased its interaction with
CD2-associated protein and nephrin, as determined by
Western analysis and co-immunoprecipitation. To evaluate
sema 3A role in podocyte survival, we quantified podocyte
apoptosis using a caspase 3 activity marker. Sema 3A induced
a 10-fold increase in podocyte apoptosis and significantly
decreased the activity of the Akt survival pathway. Our data
indicate that (1) immortalized podocytes in culture have a
functional autocrine semaphorin system that is regulated by
differentiation and ligand availability; (2) sema 3A signaling
regulates the expression and interactions of slit-diaphragm
proteins and decreases podocyte survival.
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Class 3 semaphorins (sema 3) are a family of secreted
guidance proteins that function as axon repellants during
nervous system development and are important for cardio-
vascular patterning.1 Six members of this family have been
described in vertebrates, sema 3A–3F.2 Class 3 semaphorins
bind to neuropilins (NP) 1 and 2 and signal through plexins
A1–3 and D1.3 Semaphorins and their receptors have been
detected in endothelial cells, neurons, podocytes, and renal
tubular epithelial cells in vivo and in vitro.4–9
Semaphorin 3A is known to induce growth cone collapse
and inhibit endothelial cell migration by decreasing integrin
activity, interfering with the actin cytoskeleton, and decreas-
ing focal adhesion kinase phosphorylation.6,9,10 Disruption of
the sema 3A gene results in perinatal lethality, atrial
dilatation, septum defects, and peripheral vascular patterning
abnormalities.6,11 Semaphorin 3C deficient mice have
abnormalities in the heart outflow tract septation as well as
patterning defects in the aortic arches and peripheral
vasculature.12 Deletion of plexin D1 in mice and zebrafish
resulted in severe cardiovascular abnormalities consistent
with sema 3A and 3C null phenotypes, as well as vascular
endothelial growth factor165 isoform null mutants, suggesting
that class 3 semaphorins play coordinated roles with vascular
endothelial growth factor in cardiovascular patterning.1,4,5
Semaphorin 3F disruption results in axon pathfinding
abnormalities and no evident cardiovascular phenotype.13
In the kidney, sema 3A and 3F expression is developmentally
regulated, and their mRNA transcripts are initially detected
in all epithelial cells, whereas in the mature organ they
localize to podocytes and collecting tubules.8 Sema 3A and 3F
functions in the kidney remain unknown.
Here we sought to characterize the semaphorin system
and to identify sema 3A function in mouse podocytes in
culture. Given that sema 3A signaling alters the actin
cytoskeleton in other cell types,6,9,10 we hypothesized that it
may have a similar function in podocytes. Thus, we examined
whether sema 3A regulates slit-diaphragm proteins and cell
survival. We show that immortalized podocytes have a
functional semaphorin autocrine system that is regulated by
differentiation and sema 3A. Sema 3A signaling down-
regulates podocin in a dose–response manner and decreases
its association with CD2-associated protein (CD2AP) and
nephrin. These changes in slit-diaphragm proteins are
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associated with apoptotic signals reducing podocyte survival.
Our findings suggest that sema 3A signaling may modulate
the function of the slit diaphragm and podocyte phenotype.
RESULTS
Under permissive conditions (331C), conditionally immor-
talized mouse podocytes proliferated and maintained an
epithelial phenotype. Under non-permissive conditions
(371C), podocytes differentiated and showed a dramatic
change in phenotype, as reported previously.14 The simian
virus 40 T antigen was expressed in the presence of
g-interferon at 331C, whereas it was dramatically down-
regulated at 371C (Figure 1). Synaptopodin, the prototype
marker of differentiated podocytes, was not detected at 331C
and was abundantly expressed after 7 days at 371C (Figure 1).
Expression of class 3 semaphorins and their receptors
All class 3 semaphorins (sema 3A, 3B, 3C, 3D, 3E, and 3F)
and their binding receptor NP1 and NP2 mRNAs were
expressed at similar levels in undifferentiated and differ-
entiated podocytes, as detected by semiquantitative reverse
transcriptase-PCR and shown in Figure 2a and b. In contrast,
the signaling receptors were upregulated upon podocyte
differentiation: plexin A1 (twofold), A2 (fourfold), and A3
(1.8-fold) (Figure 2c and d).
To begin to establish whether class 3 semaphorin receptors
are regulated by their ligands, differentiated podocytes were
exposed to sema 3A (50 ng/ml) or control media for 24 h
(Figure 3). rSema 3A induced a X50% decrease in sema 3B
(Figure 3a), plexin A1, A3, and D1, and reduced the
expression of plexin A2 to undetectable levels (Figure 3b).
Semaphorin 3C, 3D, and 3E, as well as NP1 and NP2 mRNA
levels remained unchanged upon exposure to rSema 3A
(Figure 3a and b). Collectively, these data suggest that sema
3A modulates the semaphorin system in podocytes by
controlling the expression level of the signaling receptors.
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Figure 1 | Immortalized murine podocytes. Morphology of cultured
podocytes in undifferentiated and differentiated conditions. Simian
virus 40 (SV40) large T antigen is expressed by undifferentiated
podocytes, whereas the podocyte-specific marker, synaptopodin, is
only expressed by differentiated podocytes.
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Figure 2 | Expression of class 3 semaphorins and their receptors
in podocytes: regulation by differentiation. (a) Semiquantitative
reverse transcriptase (RT)-polymerase chain reaction (PCR)
amplification showing sema 3A–3F detected in undifferentiated
(331C) and differentiated podocytes (371C). Glutaraldehyde
phosphate dehydrogenase (GAPDH) was amplified for loading
control of each reaction. Primers used and PCR product sizes are
indicated in Table 1. (b) Podocyte differentiation did not change class
3 semaphorin expression levels. Data are shown as mean7s.e.m.,
n¼ 5. *Po0.05. (c) Reverse transcriptase-PCR amplification of
neuropilin (NP)1, NP2, plexins A1, A2, A3 and D1 mRNAs from
undifferentiated (331C) and differentiated (371C) podocytes. GAPDH
was amplified for loading control of each reaction. Primers used and
PCR product sizes are indicated in Table 1. (d) Quantification of
RT-PCR, plexin A1, A2 and A3 increased 2–4-fold above control upon
podocyte differentiation, n¼ 4. *Po0.05.
Con Sema 3A
Con ConSema 3A
Sema 3A 50 ng/ml
Sema 3A
Sema 3B
Sema 3C
Sema 3D
Sema 3E
Sema 3F
GAPDH
PlexinD1
PlexinB2
PlexinA3
PlexinA2
PlexinA1
NP2
NP1
Sema 3A 3B 3C 3D 3E 3F
A2 A3 B2 D1 NP1 NP2PlexinA1
*
*
*
*
1.2
1
0
0.8
0.6
0.4
0.2
Fo
ld
1.2
1
0
0.8
0.6
0.4
0.2
Fo
ld
Con
b
a
*
Sema 3A 50 ng/ml
Figure 3 | Class 3 semaphorins and semaphorin receptor
regulation by sema 3A in podocytes. Differentiated podocytes
were grown in control conditions or exposed to rSema 3A (50 ng/ml)
for 24 h. (a) Reverse transcriptase PCR amplification of class 3
semaphorins. Quantification of RT-PCR showing that only sema 3B
mRNA was decreased to approximately 1/5 of control level, n¼ 4.
*Po0.05. (b) Reverse transcriptase-PCR amplification of plexins A1,
A2, A3, B2, D1, NP1 and NP2. GAPDH was amplified for loading
control of each reaction (not shown). Quantification of RT-PCR
showing that plexins A1, A3 and D1 were decreased by 50%, whereas
plexin A2 was not detected in podocytes exposed to sema 3A, n¼ 4.
*Po0.05.
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Sema 3A induces podocyte apoptosis and decreases Akt
phosphorylation
We determined that sema 3A increases podocyte apoptosis
rate following serum starvation approximately 10-fold
(Figure 4a). To explore the mechanism involved, we
examined Akt expression and phosphorylation in podocytes
exposed to sema 3A. As shown in Figure 4b, sema 3A
significantly decreased Akt serine phosphorylation, whereas
total Akt expression remained unchanged, indicating that
sema 3A decreased Akt activity.
Sema 3A regulates slit-diaphragm proteins
We determined that sema 3A signaling regulates slit-
diaphragm proteins. Recombinant sema 3A (50 ng/ml)
induced podocin downregulation, as indicated by the dose
response and time course shown in Figure 5a. CD2-
associated protein expression did not change upon exposure
to sema 3A, but its interaction with podocin decreased
significantly, as shown by co-immunoprecipitation (Figure
5b). Controls showed equal total protein and immunopre-
cipitate loading. We also examined the effect of sema 3A on
freshly isolated mouse glomeruli. When isolated glomeruli
were exposed to sema 3A, nephrin expression was unchanged
at 4 h and slightly increased above the baseline (15–20%) by
12 and 24 h (Figure 5c). Most importantly, sema 3A
decreased the interaction between nephrin and podocin, as
well as the interaction between podocin and CD2AP (Figure
5d), as assessed by co-immunoprecipitation, confirming our
findings in immortalized podocytes. Taken together, these
data suggest that sema 3A signaling disrupts the podocin/
nephrin/CD2AP complex.
DISCUSSION
In the present studies, we show that class 3 semaphorins and
their binding and signaling receptors are expressed in
immortalized mouse podocytes. Expression of plexins is
regulated by cell differentiation and availability of sema 3A.
Sema 3A induces podocyte apoptosis, indicating that
podocytes possess a functional autocrine semaphorin system.
We also demonstrate that sema 3A signaling downregulates
podocin, and decreases podocin/CD2AP and podocin/
nephrin interactions.
Podocytes are required for the development and main-
tenance of the glomerular basement membrane and the
function of the glomerular filtration barrier.15 Several
proteins, including the slit diaphragm proteins nephrin,
podocin, CD2AP, actinin-4, as well as a3-integrin, synapto-
podin, and vascular endothelial growth factor, are critical for
podocyte phenotype and function.16–19 Sema 3A expression
in podocytes was detected by in situ hybridization during
glomerular development and throughout adult life.8 In
addition, sema 3A mRNA was detected in distal tubules,
and collecting ducts.8 Sema 3A is a chemorepellent for
endothelial cells and axon growth cones.10,20,21 Ablation of
the sema 3A gene in mice resulted in perinatal lethality
associated with heart hypertrophy, septum defects, and
abnormal vascular patterning.6,11 No renal phenotype was
reported in the sema 3A null mutant mice so far and the
function of sema 3A in the kidney is unknown. We used
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Figure 4 | Sema 3A induces podocyte apoptosis and decreases
Akt phosphorylation. (a) Quantitation of podocyte apoptosis in
control conditions and upon sema 3A exposure. Data are expressed
as mean7s.e.m., n¼ 4. *Po0.05. (b) Western blot showing
phosphorylated Akt and total Akt podocyte levels in control
conditions and after 15 min of sema 3A exposure, indicating that
sema 3A decreases Akt phosphorylation, whereas total Akt remains
unchanged.
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Figure 5 | Sema 3A regulates the expression of slit-diaphragm
proteins in podocytes and isolated glomeruli. (a) Western blots
showing time and dose response to sema 3A, demonstrating that
sema 3A downregulates podocin expression. b-Actin Western blot is
shown to document equal loading. (b) Western blots showing that
sema 3A does not alter CD2-associated protein (CD2AP) expression
(b-actin Western blot is shown to document equal loading) and
co-immunoprecipitation showing that sema 3A decreases the
association of podocin and CD2AP; podocin Western blot shows
equal loading for immunoprecipitation. (c) Western blot showing that
sema 3A slightly decreases nephrin expression at 4 h and increases
nephrin expression by 15–20% at 12 and 24 h in isolated glomeruli.
b-Actin is shown for loading control. (d) Co-immunoprecipitations
showing that sema 3A decreases the association between podocin
and nephrin, as well as podocin and CD2AP in isolated glomeruli; the
corresponding podocin and CD2AP Western blots show equal
loading of immunoprecipitates.
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conditionally immortalized mouse podocytes to study the
role of sema 3A in podocyte differentiation and survival in
vitro. As described before, podocytes proliferated and
maintained an epithelial phenotype in permissive conditions
and differentiated in non-permissive conditions.14 As ex-
pected, podocyte differentiation was associated with pheno-
typic changes, expression of synaptopodin, a differentiated
podocyte marker, and inactivation of the simian virus 40 T
antigen.22
Podocytes expressed all class 3 semaphorins (sema 3A, 3B,
3C, 3D, 3E, and 3F) at similar levels in undifferentiated and
differentiated podocytes. Podocyte exposure to recombinant
sema 3A significantly decreased sema 3B mRNA level and did
not induce significant changes in sema 3A, 3C, 3D, 3E, and
3F mRNAs, indicating that the expression of most class 3
semaphorins is not regulated by sema 3A, at least in vitro.
Neuropilins, the sema 3A-binding receptors, are expressed in
endothelial cells and other cell types, including renal tubular
epithelial cells and podocytes.23–26 Here we present evidence
indicating that plexins, class 3 semaphorin signaling
receptors, are expressed in mouse podocytes, and their
expression is regulated by differentiation and ligand avail-
ability. Our data showed that plexins A1–3 and D1 mRNAs
were upregulated upon podocyte differentiation and de-
creased upon exposure to recombinant sema 3A. Neuropilin
1 and NP2 mRNA levels were not regulated by podocyte
differentiation or exposure to sema 3A. Unfortunately,
secretion of specific semaphorins to the cell supernatant
could not be evaluated because the available antibodies
crossreact between 3A, 3C, and 3F (data not shown).
We demonstrated that sema 3A induces an approximately
10-fold increase in podocyte apoptosis, as assessed by a
marker of caspase activity, and determined that sema
3A decreased Akt phosphorylation, suggesting that sema
3A-induced apoptosis is due to a decreased activity of
survival pathways. Apoptosis mediated by decreased Akt
phosphorylation was recently described in CD2AP null
podocytes.27
Our data indicate that sema 3A is involved in the
homeostasis of slit-diaphragm proteins. We showed that
sema 3A induced downregulation of podocin and decreased
its association with CD2AP and nephrin, suggesting that
sema 3A may disrupt the structural integrity of the slit-
diaphragm complex or promote its turnover. Podocin
localizes to the foot process cell membrane and associates
with CD2AP and nephrin via its COOH terminus.28 Podocin
mutations cause autosomal recessive familial focal glomer-
ulosclerosis in humans.17 Disruption of the podocin gene in
mice results in massive proteinuria associated with mesangial
sclerosis.18 Podocin downregulation has been reported in
puromycin aminonucleoside nephrosis29 and in the trans-
cription factor LMX1B mutant mice.30 We showed that sema
3A does not alter CD2AP expression level in podocytes, but
decreases its interaction with podocin, suggesting that it
modulates the dynamic interactions between these proteins.
CD2-associated protein functions as an adapter protein by
interacting with podocin and nephrin and anchoring them to
the actin cytoskeleton.28,31 CD2-associated protein null
mutation in mice caused massive proteinuria and foot
process effacement in the neonatal period and progressive
renal disease resulting in glomerulosclerosis and renal failure,
a phenotype that was prevented by introducing a CD2AP
transgene.32 In freshly isolated mouse glomeruli, sema 3A
induced mild changes in nephrin expression, but it clearly
reduced its interaction with podocin. Collectively, our data
indicate that sema 3A decreases the expression of podocin
and its interactions with other members of the nephrin/
podocin/CD2AP signaling complex. Sema 3A-induced
changes in slit-diaphragm proteins reported herein support
a possible role of sema 3A in the stability of the slit
diaphragm complex in vivo.
In summary, we showed that podocytes have a functional
autocrine sema 3A system that is regulated by differentiation
and ligand availability. We demonstrated that sema 3A
signaling induces podocyte apoptosis, downregulates podo-
cin, decreases podocin/CD2AP and podocin/nephrin inter-
actions in vitro, suggesting that sema 3A plays a role in the
homeostasis of the slit diaphragm.
MATERIALS AND METHODS
Cell culture
Conditionally immortalized mouse podocytes were grown in
Roswell Park Memorial Institute 1640 (Gibco)þ 10% fetal bovine
serumþ penicillin/streptomycin 100 U/ml (Gibco, CA, USA) with
or without recombinant mouse g-interferon (Sigma, MO, USA) in
humidified incubators with airþ 5% CO2.14 Podocytes were grown
on collagen I-coated plates at 331C with mediaþ recombinant
mouse g-interferon (10 U/ml). g-Interferon removal and tempera-
ture switch to 371C inactivated the simian virus 40 T antigen and
induced podocyte differentiation. After 10 days in differentiating
conditions, podocytes were serum starved for 24 h and exposed to
mediaþ vehicle or mediaþ recombinant rat sema 3A (2–50 ng/ml)
for 30 min–24 h as indicated.
Production of recombinant Sema 3A
Recombinant sema 3A was generated (Villegas G et al, unpublished
data). Briefly, rat sema 3A cDNA (NM_017310) (kindly provided by
A Kolodkin, John Hopkins University, Baltimore, MD, USA) was
cloned into EcoRI/NotI sites of the pHis. Parallel vector33 and
Escherichia coli BL21 DE3 Codon Plus (Stratagene, CA, USA) were
transformed and induced with 1 mM isopropylthiogalactoside to
produce the recombinant protein. The protein was extracted from
inclusion bodies in denaturing conditions (8 M urea, 100 mM
NaH2PO4, 10 mM Tris-HCl), refolded with a reducing buffer (8 M
urea, 100 mM NaCl, 50 mM Tris-HCl, 10 mM dithiothreitol, 1 mM
b-mercaptoethanol, and 1 mM ethylenediamine tetraacetate), fol-
lowed by an oxidation buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM
cysteine, 2 mM cystine, and 1 M L-arginine). Then the protein was
dialyzed against decreasing urea concentration (100 mM NaCl,
50 mM Tris-HCl, 192 mM glycine, 7 mM urea) and concentrated
using Amicons Ultra filters (Millipore, CA, USA).
Mouse glomerular isolation and processing
Adult C57BL6 glomeruli were isolated by sieving as reported
previously.34 The average purity of the glomeruli preparations was
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B60%. Glomeruli were incubated with RPMI 1640þ 10% fetal
bovine serum with and without sema 3A (50 ng/ml) for 4–24 h. At
the end of these time periods, glomeruli were pelleted by
centrifugation (1000 g, 41C, for 5 min) and resuspended in
homogenization buffer (20 mM Tris, 0.5% NP-40, 150 mM NaCl,
pH 7.5, 1% Triton X-100)þ protease inhibitors (Roche, IN,
USA)þ 1 mM Na orthovanadate. Protein extraction was performed
at 41C and insoluble material was pelleted at 14 000 g for 10 min at
41C, resuspended in homogenization buffer, and processed for
Western analysis or immunoprecipitation as described below.
Protein extraction and Western blotting
Podocytes were harvested in radioimmunoprecipitation assay lysis
buffer (50 mM Tris-HCl, pH 7.4, NaCl 150 mM, 1% Triton X-100,
and proteinase inhibitors). Protein concentration was determined by
bicinchoninic assay (Sigma) following the manufacturer’s instruc-
tions. In all, 50–100 mg protein/lane were resolved in 6–10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. The following
polyclonal primary antibodies were used for immunoblotting: anti-
simian virus 40 T large antigen (No. DP02, Oncogene), anti-
synaptopodin,22 anti-podocin,28 and anti-CD2AP were kindly
provided by Andrew Shaw, Washington University School of
Medicine, Washington University, St Louis, MO, USA; anti-nephrin
was a kind gift from Lawrence Holzman, University of Michigan,
Ann Harbre, MI, USA; anti-Akt (No. 610860, BD Biosciences,
CA, USA), anti-phosphorylated Akt ser473 (No. 9271, Cell
Signaling, MA, USA), and anti-actin (A2066, Sigma) were routinely
used as internal controls for protein loading. Secondary anti-
bodies were anti-rabbit HRP-IgG or anti-mouse HRP-IgG
(Amersham, NJ, USA), as appropriate. Enhanced chemilumines-
cence (Amersham) was used for visualization following the
manufacturer’s instructions.
Co-immunoprecipitation
Protein extracts were prepared as described above. For each
immunoprecipitation, 1 mg protein extract was pre cleared with
protein A-Sepharose (Roche) in 0.5 ml TNE buffer (250 mM NaCl,
5 mM Ethylenediamine tetraacetate, 10 mM Tris, pH 7.4, proteinase
inhibitors) for 1 h at 41C. Pre cleared extracts were immunopreci-
pitated with anti-nephrin, anti-CD2AP, and anti-podocin at 41C for
3 h. Protein A-agarose (50 ml) was added and incubated at 41C
overnight. The beads were washed five times in TNE buffer before
bound proteins were eluted by boiling the samples for 5 min in
sample buffer at 951C. Immunoprecipitated proteins were analyzed
by Western blotting.
Reverse transcription and semiquantitative polymerase chain
reaction
Total RNA was isolated from podocytes cultured in control
conditions and after 24 h exposure to sema 3A (50 ng/ml) using
Trizol reagent (Invitrogen, CA, USA). RNA concentration and
quality were assessed by spectrophotometry at 260 and 280 nm.
cDNA was generated using Superscript II reverse transcriptase first-
strand cDNA synthesis kit (Invitrogen) following the manufacturer’s
protocols. Briefly, 2–5 mg of total RNA was reverse-transcribed using
random primers and reverse transcriptase (Invitrogen) and exposing
the samples to 651C for 5 min, followed by 421C for 60 min and
751C for 15 min. Of the resulting cDNA, 1 ml was used for each PCR
amplification. Specific primers (Table 1) were designed and PCR
amplifications were performed as follows: 941C for 3 min once, 941C
for 45 s, annealing temperature as indicated in Table 1 for 30 s and
721C for 45 s, repeated 30 cycles, 721C for 5 min on the last cycle.
Glutaraldehyde phosphate dehydrogenase was used as a loading
control. A negative control without cDNA was also performed.
Polymerase chain reaction products were resolved in 1% TAE
Table 1 | Primer sequences, product sizes, and annealing temperatures
Primer Sequence Product size (bp) Tm (1C)
Sema 3A Fw 50-GTT GTA GAC CGG GTG GAT GC 400 65
Rev 50-TCG GAG CAG TGA GTC AGT GG
Sema 3B Fw 50-GAG GAC TCT GCC GCT ATC AC 306 52
Rev 50-CTC CAC ACC CAA CAC CTT CT
Sema 3C Fw 50-GCA AAA TGG CTG GCA AAG ATC C 277 60
Rev 50-CCC ATG AAA TCT ATA TAC ATT CC
Sema 3D Fw 50-AGC ACC GAC CTT CAA GAG AA 383 52
Rev 50-GTG CAT ATC TGG AGC AAG CA
Sema 3E Fw 50-GCA AAA TGG CTG GCA AAG ATC C 345 58
Rev 50-CCC ATG AAA TCT ATA TAC ATT CC
Sema 3F Fw 50-AGG TGG ATG CAG CTG ATG G 400 60
Rev 50-GGA ATT GAA ACC ACG GCA CT
Plexin A1–3 Fw 50-CCT CGA GAA CAA GAA CCA CCC CAA
Plexin A1 Rev 50-CCC TTC ACC GGC ACC TCA GGT GCA TT 304 52
Plexin A2 Rev 50-AAC ACC TTC ACT GGG ATC TCT GGA CTG TTC 301 68
Plexin A3 Rev 50-CTT CAC TGG GAC CTG GGC GCT GCC 277 56
Plexin B2 Fw 50-GAT GGA GGA CCA GAC GAA TGA 400 60
Rev 50-CAG ACC TGC GCA GCA TTA GC
Plexin D1 Fw 50-GTG ACC TCA ACG TGG GCT CTA 400 64
Rev 50-GTG ACC TCA ACG TGG GCT CTA
NP1 Fw 50-GAA GGC AAC AAC AAC TAT GA 374 58
Rev 5-ATG CTC CCA GTG GCA GAA TG
NP2 Fw 50-AAG TGG GGG AAG GAG ACT GT 310 60
Rev 50-GTC CAC CTC CCA TCA GAG AA
GAPDH Fw 50-ACC ACA GTC CAT GCC ATC AC 450 60
Rev 50-TCC ACC ACC CTG TTG CTG TA
Fw, forward; GAPDH, glutaraldehyde phosphate dehydrogenase; NP, neuropilin; Rev, reverse; SEMA, semaphorin.
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(40 mM Tris Acetate, 2 mM EDTA) agarose gels and analyzed by
Image-quantitative software (FC8000, Alpha Innotech Inc., CA,
USA). Densitometric readings were normalized for the correspond-
ing glutaraldehyde phosphate dehydrogenase reactions and
expressed as fold changes from control.
Apoptosis
Differentiated podocytes were starved for 24 h, exposed to sema 3A
(50 ng/ml) or media alone for 24 h. Then, podocytes were exposed
to the in situ apoptosis marker caspACETM FITC-VAD-FMK
(Promega, WI, USA) (10mM) for 20 min at 371C in the dark,
washed with phosphate-buffered saline, fixed in 10% formalin for
30 min at room temperature, washed three times in phosphate-
buffered saline, mounted, and examined with fluorescence micro-
scopy.
Statistical analysis
All experiments were performed at least three times, as indicated in
the figure legends or in the Results. Densitometric analysis of reverse
transcriptase-PCR amplifications and Western blot analysis of
4three independent experiments are expressed as mean7s.e.m.-
fold changes from control. In apoptosis experiments, the total
number of cells and the number of apoptotic cells were counted in
five fields per slide per condition, and the percentages of apoptotic
cells were reported as mean7s.e.m. Control and experimental
conditions were compared using unpaired t-test or analysis of
variance as appropriate. Statistical significance was deemed as
Po0.05.
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